Cannabinoid Receptor
All Product Categories
-
Cannabinoid Receptor Inhibitors
(21)
View all products
-
Cannabinoid Receptor Agonists
(60)
View all products
-
Cannabinoid Receptor Antagonists
(44)
View all products
-
Cannabinoid Receptor Activators
(9)
View all products
-
Cannabinoid Receptor Modulators
(15)
View all products
-
Cannabinoid Receptor Chemical
(1)
View all products
-
Cannabinoid Receptor Controls
(2)
View all products
-
Cannabinoid Receptor Ligands
(8)
View all products
-
Cannabinoid Receptor Related Products (294)
Related Products (294)
-
Cannabicitran
0 ImagesCat. No.: HY-118656CAS No.: 31508-71-1Cannabicitran is a cannabinoid. Cannabicitran can decrease intraocular pressure in rabbits.
-
CE-178253 benzenesulfonate
0 ImagesCat. No.: HY-169820CAS No.: 956246-95-0CE-178253 benzenesulfonate is a CB1 antagonist with central nervous system activity.
-
Olivetol-d9
0 ImagesCat. No.: HY-W008364S1CAS No.: 137125-92-9
-
GW 833972A free base
0 ImagesCat. No.: HY-180365CAS No.: 667905-37-5GW 833972A free base is a selective CB₂ receptor agonist with pEC₅₀ of the human CB₂ receptor for GW 833972A free base of 7.3, and its selectivity for the CB₂ receptor is approximately 1000 times higher than that for the CB₁ receptor. GW 833972A free base inhibits induced neuronal depolarization and suppresses coughing caused by citric acid in guinea pig models. GW 833972A free base can be used for the study of chronic cough.
-
CB2 receptor agonist 4
0 ImagesCat. No.: HY-153693CAS No.: 2052602-31-8CB2 receptor agonist 4 (Compound 8) is a highly selective cannabinoid receptor type 2 (CB2 Receptor) agonist with an EC50 of 13.99 nM. CB2 receptor agonist 4 shows no significant activity against cannabinoid receptor type 1. CB2 receptor agonist 4 can be used for the research of pain and immune-related diseases.
-
2-Linoleoyl glycerol-d5
0 ImagesCat. No.: HY-W770198Synonyms: 2-Monolinolein-d5; 2-Monolinoleoylglycerol-d52-Linoleoyl glycerol-d5 (2-Monolinolein-d5; 2-Monolinoleoylglycerol-d5) is the deuterium labeled 2-Linoleoyl glycerol (HY-130311). 2-Linoleoyl glycerol (2-Monolinolein; 2-Monolinoleoylglycerol) is a monoacylglycerol that is an antagonist and partial agonist at the type 1 cannabinoid CB1 receptor. The potency of 2-Linoleoyl glycerol can be enhanced by JZL195 (HY-15250), an inhibitor of FAAH and MAGL, and inhibited by the CB1 antagonist AM251 (HY-15443) and Cannabidiol. As a CB1 antagonist, 2-Linoleoyl glycerol does not enhance, but only attenuates, the activity of the CB1/CB2 receptor ligands cannabinoids (AEA) and 2-arachidonoylglycerol (2-AG).
-
IDFP
0 ImagesCat. No.: HY-121637CAS No.: 615250-02-7Synonyms: iso-PrdodecylfluorophosphonateIDFP (iso-Prdodecylfluorophosphonate) is a chemical affinity probe for the cannabinoid CB1 receptor.
-
CB2R ligand-1
0 ImagesCat. No.: HY-175730CAS No.: 2816933-22-7CB2R ligand-1 (Compound L14) is a selective Cannabinoid type 2 receptor (CB2R) ligand with a with Ki of 0.16 nM for CB2R over CB1R. CB2R ligand-1 as be used as a tracer for positron emission tomography (PET) imaging of neurodegenerative diseases, inflammation and cancer.
-
1'-Naphthoyl-2-methylindole
0 ImagesCat. No.: HY-121947CAS No.: 80749-33-31'-Naphthoyl-2-methylindole (Compound 88) is a cannabinoid mimetics and an inhibitor for Win 55212-2, that inhibits 34% of [3H]Win 55212-2 binding to cannabinoid receptors at 3 μM.
-
15(S)-HETE Ethanolamide
0 ImagesCat. No.: HY-130357CAS No.: 161744-53-215(S)-HETE Ethanolamide is a cannabinoid analog the CB1 receptor (Ki of 600 nM).
-
MDMB-FUBICA
0 ImagesCat. No.: HY-168750CAS No.: 1971007-91-6MDMB-FUBICA is a potent agonist of the cannabinoid receptors with psychoactive properties. MDMB-FUBICA can be used in the study of electronic cigarette.
-
BI-5756
0 ImagesCat. No.: HY-171883CAS No.: 1332485-18-3BI-5756 is a CETP inhibitor and cannabinoid receptor 1 (CB1) agonist. BI-5756 can significantly increase HDL-C levels and reduce LDL-C levels. BI-5756 can also enhance the function of regulatory T cells while maintaining T cell-mediated anti-tumor activity. BI-5756 can directly inhibit the growth of tumor cells and upregulate the expression of MHC I, MHC II, and CD80 on tumor cells. BI-5756 has a protective effect in graft-versus-host disease models. BI-5756 can be used in research on tumors, graft-versus-host disease, and metabolic diseases.
-
CB1R antagonist 2
0 ImagesCat. No.: HY-172409CB1R antagonist 2 (Compound 11g) is the antagonist for cannabinoid receptor 1 (CB1R), that inhibits MAPK/NF-κB signaling pathway and exhibits anti-inflammatory activity. CB1R antagonist 2 inhibits LPS (HY-D1056)-induced IL-6, IL-1β and TNF-α expressions in RAW264.7. CB1R antagonist 2 ameliorates OVA-induced allergic rhinitis in mouse models.
-
Hemopressin(human, mouse) TFA
0 ImagesCat. No.: HY-P1091ACAS No.: 1431329-48-4Hemopressin TFA is a nonapeptide derived from the α1-chain of hemoglobin, is originally isolated from rat brain homogenates. Hemopressin TFA is orally active, selective and inverse agonist of CB1 cannabinoid receptors. Hemopressin TFA exerts antinociceptive action in inflammatory pain models.
-
2-Arachidonoylglycerol-d11
0 ImagesCat. No.: HY-W011051S2CAS No.: 2260670-54-82-Arachidonoylglycerol-d11 is deuterium labeled 2-Arachidonoylglycerol.2-Arachidonoylglycerol is a second endogenous cannabinoid ligand in the central nervous system.
-
N-Oleoyl glycine (Standard)
0 ImagesCat. No.: HY-113204RCAS No.: 2601-90-3Diludine (Standard) is the analytical standard of Diludine. This product is intended for research and analytical applications. Diludine has antioxidant properties, targeting oxidative stress-related pathways. By improving antioxidative status and reducing β-hydroxybutyrate levels, Diludine alleviates oxidative stress during the parturition period in dairy cows. It is primarily used during the transition period in dairy cows to increase milk yield and milk fat content, as well as to improve health during parturition.
-
MDA-19 N-(5-hydroxyhexyl)
0 ImagesCat. No.: HY-173543MDA-19 N-(5-hydroxyhexyl) is a cannabinoid receptor modulator targeting CB1R/CB2R. MDA-19 N-(5-hydroxyhexyl) is used to study neurological diseases, cancer, and pain regulation.
